Meconeuron Tablet contains Methylcobalamin 500 mcg, an active form of vitamin B12 essential for neurological function and hematopoiesis. It is primarily indicated for the treatment and prevention of vitamin B12 deficiency, which may manifest as peripheral neuropathy, megaloblastic anemia, or neurological disorders associated with cobalamin deficiency. Methylcobalamin plays a critical role in the synthesis of myelin, the protective sheath surrounding nerve fibers, thereby supporting nerve regeneration and repair. This medication is commonly prescribed for patients with diabetic neuropathy, alcoholic neuropathy, and other neuropathic conditions where nerve damage is evident. Additionally, Meconeuron Tablet aids in the maintenance of normal homocysteine levels, contributing to cardiovascular health. The tablet is administered orally, with dosage and duration determined by the severity of deficiency and clinical response. It is generally well-tolerated, with minimal adverse effects; however, hypersensitivity reactions, though rare, may occur. Meconeuron Tablet should be used under medical supervision, especially in patients with renal impairment or those receiving concurrent therapies. Regular monitoring of vitamin B12 levels and clinical symptoms is recommended to assess therapeutic efficacy and guide treatment adjustments.